Tuberculosis and Respiratory Diseases

Search

Page Path

HOME
Search

Reviews

Contemporary Strategies: Incorporating Immunotherapy into Stage III Non-Small Cell Lung Cancer Treatment: Da Hyun Kang, Chaeuk Chung; Received October 8, 2023 Accepted March 22, 2024 Published online March 28, 2024; DOI: https://doi.org/10.4046/trd.2023.0162 [Accepted]; PDF

Lung Cancer

Recent Advances in Adjuvant Therapy for Non–Small-Cell Lung Cancer: Mi-Hyun Kim, Soo Han Kim, Min Ki Lee, Jung Seop Eom; Tuberc Respir Dis. 2024;87(1):31-39. Published online November 15, 2023; DOI: https://doi.org/10.4046/trd.2023.0085; Full text PubReader ePub PDF

Review Articles

Current Status of Immunotherapy for Lung Cancer and Future Perspectives: Ho Cheol Kim, Chang-Min Choi; Tuberc Respir Dis. 2020;83(1):14-19. Published online August 31, 2019; DOI: https://doi.org/10.4046/trd.2019.0039
Web of Science 19 Crossref 18; Full text PubReader PDF

Chemotherapy for Lung Cancer in the Era of Personalized Medicine: Seung Hyeun Lee; Tuberc Respir Dis. 2019;82(3):179-189. Published online December 20, 2018; DOI: https://doi.org/10.4046/trd.2018.0068
Web of Science 39 Crossref 43; Full text PubReader PDF

Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Chi Young Jung, Scott J. Antonia; Tuberc Respir Dis. 2018;81(1):29-41. Published online December 29, 2017; DOI: https://doi.org/10.4046/trd.2017.0120
Web of Science 19 Crossref 21; Full text PubReader PDF

Respiratory Review of 2014: Asthma: Ho Il Yoon; Tuberc Respir Dis. 2014;77(6):237-242. Published online December 31, 2014; DOI: https://doi.org/10.4046/trd.2014.77.6.237
Web of Science 7 Crossref 4; Full text PubReader PDF

Immunotherapy for Non-Small Cell Lung Cancer: Sung Ho Yoon; Tuberc Respir Dis. 2014;77(3):111-115. Published online September 30, 2014; DOI: https://doi.org/10.4046/trd.2014.77.3.111
Web of Science 16 Crossref 16; Full text PubReader PDF

Original Articles

Antitumor and Antimetastatic Effects of Toxoplasma Gondii in Mice with Lewis Lung Carcinoma.: Ju Ock Kim, Sung Soo Jung, Hee Sun Park, Myoung Hoon Kim, Young Ha Lee, Sun Young Kim; Tuberc Respir Dis. 2002;52(4):317-329. Published online April 1, 2002; DOI: https://doi.org/10.4046/trd.2002.52.4.317; PDF

Volume 87, No. 2

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

Impact Factor

2.9

MOST VIEWED MOST CITED

9,557	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
4,375	Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine
2,559	Early Mobilization and Rehabilitation of Critically-Ill Patients
14,790	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
2,331	Association between Antacid Exposure and Risk of Interstitial Lung Diseases

Cited By 26	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
Cited By 14	Tuberculosis: Republic of Korea, 2021
Cited By 12	Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Cited By 10	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
Cited By 10	Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae

ARTICLE & TOPICS

Article category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

prev

next